Experience

Debiopharm Innovation Fund and Benchstrength co-lead a C$7.9 million seed funding round for Altis Labs Inc.

Reading Time 1 minute read
Share

Overview

Client

Debiopharm Innovation Fund

On June 22, 2023, Altis Labs Inc., a computational imaging company accelerating clinical trials with artificial intelligence, announced the closing of its C$7.9 million seed funding round co-led by Debiopharm Innovation Fund and Benchstrength.

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, provides funding and guidance for companies with an ambition to improve the patient journey and transform pharmaceutical research and development.

Fasken advised Debiopharm Innovation Fund with a team led Will Shaw and Sylvie Bourdeau, including Alec McIlwraith-Black, Hashim Ghazi, Chris Dittrich, and Laura Fetter.

Jurisdiction

  • Ontario

Team

  • Will Shaw, Partner | National Co-Leader, Emerging Technology & Venture Capital, Toronto, ON, +1 416 865 4554, [email protected]
  • Sylvie Bourdeau, Partner | Corporate/Commercial, Montréal, QC, +1 514 397 4388, [email protected]
  • Alec McIlwraith-Black, Associate | Emerging Technology & Venture Capital, Toronto, ON, +1 416 868 3468, [email protected]
  • Chris Dittrich, Partner | Emerging Technology & Venture Capital, Toronto, ON, +1 416 868 3363, [email protected]
  • Laura Fetter, Counsel | Emerging Technology & Venture Capital, Toronto, ON, +1 416 865 4450, [email protected]
Will Shaw Toronto Lawyer Will Shaw Partner | National Co-Leader, Emerging Technology & Venture Capital Toronto, ON +1 416 865 4554
Sylvie Bourdeau associée/partner Montréal Sylvie Bourdeau Partner | Corporate/Commercial Montréal, QC +1 514 397 4388
Alec McIlwraith-Black Toronto Lawyer Alec McIlwraith-Black Associate | Emerging Technology & Venture Capital Toronto, ON +1 416 868 3468
Chris Dittrich Toronto Lawyer Chris Dittrich Partner | Emerging Technology & Venture Capital Toronto, ON +1 416 868 3363
Laura Fetter Director of Innovation Laura Fetter Counsel | Emerging Technology & Venture Capital Toronto, ON +1 416 865 4450